GENADYNE BIOTECHNOLOGIES INC.

Genadyne Biotechnologies Inc. specializes in negative-pressure wound therapy (NPWT) systems, which promote wound healing by applying controlled suction. Their portfolio includes electric single-use NPWT units, canisters for fluid collection, and foam dressings—both standard and antimicrobial (e.g., silver-infused). They also produce silicone-based foam dressings with adhesive borders, instillation-capable foams for localized treatment, and specialized irrigation NPWT units designed for complex wound care scenarios.

Genadyne Biotechnologies Inc. is based in the United States. Their devices are listed in two key regulatory registries: the EU’s eudamed database for European market compliance and the FDA’s Unique Device Identifier (UDI) database for tracking in the US. These listings help healthcare providers and regulators identify and verify the devices under their respective regulatory frameworks.

Genadyne’s devices fall into multiple FDA classification categories depending on their design and intended use. Their products are classified as Class I (low-risk, general controls), Class II (moderate-risk, requiring special controls), Class IIa (a subset of Class II with additional performance standards), Class IIb (higher-risk Class II devices), and Class III (high-risk, requiring premarket approval). The classification determines the regulatory pathway, with Class III devices requiring the most stringent scrutiny due to their potential risks.

Genadyne offers both antimicrobial and non-antimicrobial foam dressings to address different wound care needs. The antimicrobial variants (e.g., silver-infused foams like *Silver Foam Medium*) incorporate antimicrobial agents to reduce bacterial colonization and infection risk in chronic or contaminated wounds. In contrast, non-antimicrobial foams (e.g., *GentilFoam Soft Silicone*) focus on mechanical debridement and moisture balance without added antimicrobial properties. The choice depends on the wound’s condition and infection status.

Healthcare providers may consult the FDA’s UDI database to verify the legitimacy, compliance status, and specific details of Genadyne’s devices before use. The UDI system ensures traceability, reducing risks of counterfeit or mislabeled products. For Genadyne’s NPWT systems—such as their *DUO Canister Set* or *Foam Dressing Large Instill*—this database provides critical information like device identifiers, manufacturing dates, and lot numbers, which are essential for inventory management, recall tracking, and patient safety.